(3S,4S)-3-((R)-(tert-Butyldimethyl-silyloxy)ethyl)-4((R)-carboxyethyl)-2-azetidinone

CAS: 90776-58-2

Ref. 3D-FB149807

Informação sobre produto

• Nome: (3S,4S)-3-((R)-(tert-Butyldimethyl-silyloxy)ethyl)-4((R)-carboxyethyl)-2-azetidinone
• Sinónimos: (3S,4S)-4-[(R)-1-carboxyethyl]-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinonebeta-Methylazetidin-2-one, (2R)-2-{(2S,3S)-3-[(1R)-1-{[tert-butyl(dimethyl)silyl]oxy}ethyl]-4-oxoazetidin-2-yl}propanoic acid, (3S 4S)-3-[(R)-1-(T-Butyldimethylsilyloxy)Ethyl]-4-[(R)-1-Carboxyethyl]-2-Azetidinone, (3S,4S)-3-[(1R)-1-[(tert-Butyldimethylsilyl)oxy]ethyl]-4-((1R)-1-carboxyethyl)azetidin-2-one, (3S,4S)-3-[(R)-(Butyldimethylsilyloxy)Ethyl]-4-[(R)-Carboxyethyl]-2-Azetidinone, (3S,4S)-3-[(R)-1-(Tert-Butyldimethylsiloxy)Ethyl]-4-[(R)-1-Carboxyethyl]-2-Azetidinone, (3S,4S)-3-[(R)-1-(Tert-Butyldimethylsilyloxy)Ethyl]-4-[(R)-1-Carboxyethyl]-2-Azetidinone, (3S,4S)-4-[(R)-1-carboxy-ethyl]-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinone, (3S,4S)-4-[(R)-1-carboxyethyl]-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinone, (R)-2-((2S,3S)-3-((R)-1-(Tert-Butyldimethylsilyloxy)Ethyl)-4-Oxoazetidin-2-Yl)Propanoic Acid, (R)-2-[(3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-2-oxoazetidin-4-yl]propionic acid, (αR,2S,3S)-3-[(1R)-1-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methyl-4-oxo-2-azetidineacetic acid, 1-Bma, 2-Azetidineacetic acid, 3-[(1R)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methyl-4-oxo-, (αR,2S,3S)-, 2-Azetidineacetic acid, 3-[1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methyl-4-oxo-, [2S-[2α(S*),3β(S*)]]-, 4-BMA(for Meropenem), 4-Bma, 4Bma, Side Chain For Imipenem, [2R-[2α(R*),3β(R*)] ]-3-[1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methl-4-oxo-2-azetidineacetic acid, Β-Methylazetidin-2-One
• CAS: 90776-58-2

Descrição

(3S,4S)-3-((R)-(tert-Butyldimethyl-silyloxy)ethyl)-4((R)-carboxyethyl)-2-azetidinone (SBET) is a propionylated carbapenem antibiotic. It is an analog of ertapenem, a carbapenem antibiotic that has been developed for the treatment of multidrug resistant Gram-negative bacteria. SBET has been shown to have stereospecificity in vitro studies and to be metabolized by organic acids. The reaction yields are dependent on the solvents used. The functional groups on SBET are important for its activity as a carbapenem antibiotic.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 301.45 g/mol
• Fórmula: C₁₄H₂₇NO₄Si
• Pureza: Min. 95%